Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P51532 (
transcriptional activator
)
6,546
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The zinc finger protein early growth response 1 (Egr-1) is a
transcriptional activator
involved in the regulation of growth and differentiation. Egr-1 has a large activating domain and three zinc finger motifs that function as a DNA binding region. We show here that a third functional domain of the Egr-1 protein, localized between the extended activation domain and the zinc finger DNA binding region, acts as a transcriptional repressor domain when fused to a heterologous DNA binding domain (DBD). Through protein-protein interaction this inhibitory domain of Egr-1 brings the transcriptional corepressor
NAB1
in close proximity to the transcription unit.
NAB1
is expressed ubiquitously in human cell lines as shown by RNase protection mapping. Overexpression studies revealed that
NAB1
is able to completely block transcription mediated by Egr-1. In addition, the transcriptional repression activity of a fusion protein containing the inhibitory domain of Egr-1 and the DBD of the yeast transcription factor GAL4 was increased by overexpression of
NAB1
. A fusion protein consisting of the DBD of GAL4 and the coding region of human
NAB1
repressed transcription from model promoters with engineered upstream GAL4 binding sites. The GAL4-
NAB1
fusion protein functioned from proximal and distal positions indicating that
NAB1
displays transcriptional repressor activity at any position within the transcription unit. Thus, the biological function of the inhibitory domain of Egr-1 is solely to provide a docking site for
NAB1
via protein-protein interaction.
...
PMID:The human transcriptional repressor protein NAB1: expression and biological activity. 1101 54